Inozyme Pharma Inc.

1.20
0.00 (0.00%)
At close: Mar 03, 2025, 12:37 PM

Inozyme Pharma Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19 FY18
Cash & Equivalents 34.59M 32.91M 23.32M 159.9M 31.61M 35.97M
Short-Term Investments 154M 94.95M 88.48M 119.66M 15.53M 7.2M
Long-Term Investments n/a 354K 354K 12.2M 130K n/a
Other Long-Term Assets 2M 3.81M 3.41M 3.54M 56K 34K
Receivables 385K 115K 62K 155K 104K 31K
Inventory n/a -115K -62K -12.35M n/a n/a
Other Current Assets 7.28M 3.41M 3.48M 3.12M 190K 73K
Total Current Assets 196.25M 131.39M 115.34M 150.98M 47.46M 43.27M
Property-Plant & Equipment 2.59M 3.64M 4.44M 2.65M 298K 242K
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 4.6M 7.8M 8.2M 18.38M 484K 276K
Total Assets 200.85M 139.19M 123.54M 169.36M 47.94M 43.54M
Account Payables 1.17M 2.54M 2.39M 3.07M 901K 984K
Deferred Revenue n/a 3.81M n/a 279K n/a n/a
Short-Term Debt 910K 1.63M 1.46M n/a n/a n/a
Other Current Liabilities 12.61M 10.54M 7.78M 6.9M 2.33M 1.41M
Total Current Liabilities 14.69M 14.71M 11.63M 9.97M 3.24M 2.39M
Long-Term Debt 45.68M 5.96M 2.64M 1.29M n/a n/a
Other Long-Term Liabilities n/a 124K n/a n/a n/a 55.03M
Total Long-Term Liabilities 45.68M 6.09M 2.64M 1.29M 77.93M 55.03M
Total Liabilities 60.37M 20.8M 14.27M 11.26M 81.16M 57.42M
Total Debt 46.59M 6.78M 3.37M 1.29M n/a n/a
Common Stock 6K 4K 2K 2K 1K 1K
Retained Earnings -285.93M -214.76M -147.7M -91.08M -34.65M -14.93M
Comprehensive Income 41K -205K 18K 2K 5K -2K
Shareholders Equity 140.48M 118.59M 109.27M 158.1M -33.22M -13.88M
Total Investments 154M 94.95M 88.48M 131.86M 15.53M 7.2M